National
Annual Survey of Industries (ASI) for the Financial Years 2020-21 and 2021-22
⇒ Ministry of Statistics and Programme Implementation (MoSPI) has released the results of Annual Survey of Industries (ASI) for the reference periods April 2020 to March 2021 (i.e. financial year 2020-21) referred to as ASI 2020-21 and for the reference period April 2021 to March 2022 (i.e. financial year 2021-22) referred to as ASI 2021-22.
- The field work for these surveys were carried out during April 2022 to November 2022 for ASI 2020-21 and during March 2023 to September 2023 for ASI 2021-22.
- A considerable part of the reference period for ASI 2020-21 was affected by the first wave of Covid-19 pandemic that witnessed lockdown and major disruption not only in India but also globally. Part of reference period for ASI 2021-22 witnessed the second wave of the pandemic.
Objective:
Annual Survey of Industries is conducted with the primary objective to provide a meaningful insight into the dynamics of change in the composition, growth and structure of various manufacturing industries in terms of output, value added, employment, capital formation and a host of other parameters. It provides valuable input to the National Accounts Statistics at national and state level. The results are prepared at state and major industry level.
Important Points from the ASI 2020-21 and ASI 2021-22 results:
- The ASI results for the year 2021-22 exhibits the resilience shown by the Indian manufacturing sector and tells the unique turn-around story of the Indian manufacturing sector after the adverse effect of pandemic witnessed in 2020-21 in terms of output and input contraction and also a marginal fall in employment.
- The results show that while the Gross Value Added (GVA) grew by 8.8% in current prices in the year 2020-21 over 2019-20 mainly on account of sharp fall in input (4.1%) that more than offset an output contraction (1.9%) in the sector in a year which was affected by COVID; the GVA has gone up significantly by 26.6% in 2021-22 over 2020-21 riding on a high growth in the industrial output which grew by more than 35% in value terms during this period in current prices.
- Gross Value Added is calculated by subtracting intermediate consumption (input) from the gross value of output.
- The year 2021-22 witnessed a sharp rise in level as well as in growth of majority of the important economic parameters like invested capital, input, output, GVA, net income and net profit registered by the sector and even surpassed the pre-pandemic level in absolute value terms.
- The main drivers of this growth in 2021-22 were industries like Manufacture of Basic metal, Coke & Refined Petroleum Products, Pharmaceutical Products, Motor vehicles, Food Products and Chemical and Chemical products. These industries, taken together, contributed about 56% of the total GVA of the sector and showed a GVA growth of 34.4% and output growth of 37.5% in comparison to 2020-21.
- Due to Covid pandemic, there had been a marginal fall in employment in 2020-21 which was more than compensated in the subsequent year i.e. in 2021-22 with total estimated employment in the sector showing a robust growth of 7.0 % year-on-year (Y-o-Y). In fact, the estimated number of persons engaged in this sector in 2021-22 has exceeded the pre-pandemic level (that is 2018-19) by more than 9.35 lakh. At the same time, average emoluments also registered an increase with average salary earned per employee in this sector had gone up by 1.7% in 2020-21 and by 8.3% in 2021-22 in comparison to respective previous years.
- Among the major states, in terms of GVA, Gujarat remained at the top in 2020-21 and in the second position in 2021-22 while Maharashtra ranked first in 2021-22 and second in 2020-21. These two states were followed by Tamil Nadu, Karnataka and Uttar Pradesh in both the years. The top five states, taken together contributed about 53% of the total manufacturing GVA of the country in 2020-21 as well as in 2021-22.
- The top five states employing highest number of persons in this sector were Tamil Nadu, Gujarat, Maharashtra, Uttar Pradesh and Haryana in ASI 2020-21 as well as in ASI 2021-22. Taken together, these states contributed about 54% of total manufacturing employment in both the years.
Union Minister Dr Jitendra Singh launches Multi-disciplinary Doctoral Courses in Bio-Sciences
⇒ Union Minister of State (I/C) Science & Technology; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh launched multi-disciplinary doctoral courses in Bio-Sciences to address global health challenges in February 2024.
Delivering the key-note address at the launch of “i3c BRIC-RCB PhD Programme” in Biosciences in New Delhi, Dr Jitendra Singh announced that 1000 Ph.D. students will be enrolled in the next five years to drive innovation in the critical healthcare sector.
- This Ph.D. programme is designed on the four pillars of ideation, immersion, innovation and collaboration.
- Regional Centre for Biotechnology (RCB), an Institution of National Importance under the DBT, along with iBRIC (institutions of BRIC) has rolled out a globally competitive interdisciplinary Ph.D. program- “The i3c BRIC-RCB PhD Programme in Biosciences.
» The DBT-Biodesign Program promotes and nurtures Med-tech innovators in the country.
- At present, six Biodesign Centers across the Country twining over 20 leading medical schools and technical institutions are providing the biodesign capacity building and indigenous med-tech innovations.
Biodesign process:
» The Biodesign process is a ‘3-i’ process i.e. – Identify, Invent, and Implement.
- The program provides on-site training on biodesign processes to aspiring medical technology innovators to identify unmet health-related needs and to invent health technologies.
- Overall aim is to address the unmet national needs and to prepare the innovators/entrepreneurs to translate the technologies into patient care through start-up incorporations.